Cytori Therapeutics said today it plans to acquire the liposomal nanoparticle technology platform of Azaya Therapeutics for up to $170 million, in a deal designed to expand and complement the buyer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback